GlassScriptPhysician profile
George C Bazaco
NPI 1922000256
$16,413.59
in general payments reported to CMS, 2019-2025
44 companies · $2,418 in 2025
The $2,418 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,385 · 2020: $1,841 · 2021: $2,217 · 2022: $2,669 · 2023: $2,710 · 2024: $2,174 · 2025: $2,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,199 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,199.28 |
| Education | $102.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,240.60 | 2019-2025 | Breztri, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $3,032.74 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Regeneron Healthcare Solutions, INC. | $1,741.61 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,679.43 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Mylan Specialty L.P. | $886.19 | 2019-2024 | Yupelri |
| Insmed, INC. | $852.96 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $745.73 | 2019-2025 | |
| Harmony Biosciences LLC | $498.78 | 2020-2025 | Wakix |
| Electromed, INC. | $264.63 | 2019-2025 | Smartvest |
| Mallinckrodt Enterprises LLC | $219.39 | 2019 | |
| Genentech USA, INC. | $180.23 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $166.91 | 2021-2024 | Glassia |
| Amgen INC. | $162.86 | 2021-2025 | Tezspire |
| Mallinckrodt Hospital Products INC. | $161.80 | 2020-2024 | Acthar |
| Grifols USA, LLC | $161.73 | 2019-2025 | Prolastin-C Liquid |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $160.74 | 2019-2025 | Vest Therapy Und |
| Verona Pharma, INC. | $142.87 | 2025 | Ohtuvayre |
| Intuitive Surgical, INC. | $116.24 | 2023 | |
| Sunovion Pharmaceuticals INC. | $107.76 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $94.39 | 2020-2025 | Opsumit, Uptravi |
| Viatris Specialty LLC | $65.75 | 2025 | Yupelri |
| Ani Pharmaceuticals, INC. | $65.38 | 2022-2023 | Purified Cortrophin Gel |
| Teva Pharmaceuticals USA, INC. | $63.66 | 2020-2023 | |
| Vanda Pharmaceuticals INC. | $56.31 | 2020-2022 | |
| Baxter Healthcare | $54.11 | 2023-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Shionogi INC | $50.28 | 2024 | Fetroja |
| Merck Sharp & Dohme LLC | $39.95 | 2023-2024 | Zerbaxa, Dificid |
| 3b Medical, INC. | $38.32 | 2025 | Luna |
| Inogen, INC. | $36.59 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Jazz Pharmaceuticals INC. | $33.18 | 2025 | |
| Alexion Pharmaceuticals, INC. | $30.99 | 2019 | |
| Portola Pharmaceuticals, LLC | $30.68 | 2019 | |
| Inspire Medical Systems, INC. | $30.08 | 2024 | Inspire |
| Lilly USA, LLC | $25.04 | 2025 | Zepbound |
| Pfizer INC. | $24.09 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.89 | 2025 | |
| Vapotherm INC | $20.35 | 2021 | |
| Astellas Pharma US INC | $19.10 | 2019 | |
| Circassia INC. | $15.96 | 2019 | |
| United Therapeutics Corporation | $15.62 | 2025 | Tyvaso |
| Itamar Medical INC | $15.59 | 2021 | |
| Gilead Sciences, INC. | $14.74 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $14.05 | 2024 | Lumryz |
| Pulmonx Corporation | $13.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Bazaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.